TLPH Q3 2024 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q3 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$2M

Operating Income

-$4M

Net Income

-$3M

EPS (Diluted)

$-0.13

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$234,000

Balance Sheet

Total Assets

$21M

Total Liabilities

$11M

Stockholders' Equity

$10M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$117,000	-100.0%
Gross Profit	-$2M	-$1M	-93.5%
Operating Income	-$4M	-$3M	-13.3%
Net Income	-$3M	-$1M	-147.1%